MS INCA HC I Hospital do Cancer I

Rio de Janeiro 20231-130

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Non-Hodgkin

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed